These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38953514)

  • 1. Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire.
    Drysdale H; Marlow LAV; Lim A; Waller J
    Health Expect; 2024 Aug; 27(4):e14118. PubMed ID: 38953514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    Drysdale H; Marlow LA; Lim A; Sasieni P; Waller J
    J Med Screen; 2022 Sep; 29(3):194-202. PubMed ID: 35389282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
    Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
    J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
    [No Abstract]   [Full Text] [Related]  

  • 4. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 6. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.
    Song J; Ni YH; Fang J; Qu SX; Chen XY; Wu WL; Zhang WC; Qin JF
    BMC Womens Health; 2024 Jun; 24(1):343. PubMed ID: 38877469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
    Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen).
    Lim AWW; Deats K; Gambell J; Lawrence A; Lei J; Lyons M; North B; Parmar D; Patel H; Waller J; Warwick J; Sasieni PD;
    EClinicalMedicine; 2024 Jul; 73():102672. PubMed ID: 39429813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    Andersson S; Belkić K; Mints M; Östensson E
    J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
    PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women.
    Bosgraaf RP; Ketelaars PJ; Verhoef VM; Massuger LF; Meijer CJ; Melchers WJ; Bekkers RL
    Prev Med; 2014 Jul; 64():108-13. PubMed ID: 24736093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
    Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
    J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
    Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
    J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
    Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
    Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
    Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.